Rafferty Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.38M Buy
415,038
+161,274
+64% +$924K 0.01% 561
2025
Q1
$2.07M Sell
253,764
-79,627
-24% -$650K 0.01% 570
2024
Q4
$3.14M Sell
333,391
-73,883
-18% -$696K 0.01% 514
2024
Q3
$4.35M Sell
407,274
-49,395
-11% -$528K 0.01% 454
2024
Q2
$4.53M Sell
456,669
-288,905
-39% -$2.87M 0.02% 441
2024
Q1
$8.78M Sell
745,574
-49,777
-6% -$586K 0.03% 317
2023
Q4
$11.3M Buy
795,351
+87,112
+12% +$1.24M 0.05% 238
2023
Q3
$8.61M Buy
708,239
+59,727
+9% +$726K 0.05% 261
2023
Q2
$8.15M Buy
648,512
+53,811
+9% +$676K 0.05% 266
2023
Q1
$6.6M Sell
594,701
-95,068
-14% -$1.05M 0.04% 312
2022
Q4
$8.42M Buy
689,769
+83,009
+14% +$1.01M 0.07% 239
2022
Q3
$6.34M Buy
606,760
+136,451
+29% +$1.42M 0.07% 271
2022
Q2
$5.05M Sell
470,309
-118,275
-20% -$1.27M 0.05% 275
2022
Q1
$5.57M Buy
588,584
+63,739
+12% +$604K 0.03% 363
2021
Q4
$6.06M Buy
524,845
+220,295
+72% +$2.54M 0.03% 298
2021
Q3
$2.91M Buy
304,550
+58,924
+24% +$563K 0.02% 494
2021
Q2
$2.37M Sell
245,626
-63,446
-21% -$612K 0.01% 634
2021
Q1
$3.05M Buy
309,072
+266,892
+633% +$2.64M 0.02% 484
2020
Q4
$974K Sell
42,180
-111,751
-73% -$2.58M 0.01% 502
2020
Q3
$2.17M Buy
153,931
+66,546
+76% +$940K 0.03% 394
2020
Q2
$1.32M Buy
87,385
+51,694
+145% +$780K 0.02% 468
2020
Q1
$330K Sell
35,691
-267,635
-88% -$2.47M 0.01% 414
2019
Q4
$2.95M Sell
303,326
-345,646
-53% -$3.37M 0.05% 223
2019
Q3
$5.21M Buy
648,972
+213,367
+49% +$1.71M 0.08% 149
2019
Q2
$5.44M Buy
435,605
+79,212
+22% +$989K 0.1% 144
2019
Q1
$4.85M Buy
+356,393
New +$4.85M 0.08% 144